The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 21
- 21 new
- Median first-year cost
- $361,688
- $7,531,348 in all
- Institutions
- 18
- 21 contact PIs
Awards by fiscal year
0
0
0
0
0
6
8
7
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- DUKE UNIVERSITY2
- OREGON HEALTH & SCIENCE UNIVERSITY2
- UNIVERSITY OF IOWA2
- BAYLOR COLLEGE OF MEDICINE1
- BOSTON CHILDREN'S HOSPITAL1
and 13 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-M (F1))21
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2021 | Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa1U01HL157872-01 | McGann, Patrick Thomas | RHODE ISLAND HOSPITAL, RI | First-year cost $369,859 | Study section ZHL1 |
| FY2021 | Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis1R01HL146404-01A1 | Chorba, John S | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | First-year cost $363,375 | Study section ZHL1 |
| FY2021 | Optimizing Intensive Care Unit Staffing in the United States1R01HL156880-01 | Gershengorn, Hayley Beth | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | First-year cost $359,567 | Study section ZHL1 |
| FY2021 | Epigenetic Regulation of the Maturation and Function of Lung Epithelium by the SWI/SNF Proteins ARID1A and ARID1B.1R01HL156860-01 | Swarr, Daniel, T (md) Todd | CINCINNATI CHILDRENS HOSP MED CTR, OH | First-year cost $357,750 | Study section ZHL1 |
| FY2021 | Fractured Schedules: Skeletal Effects of Acute and Chronic Night Shift Work1R01HL151332-01A1 | Swanson, Christine M | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $355,792 | Study section ZHL1 |
| FY2021 | Harnessing Big Data to Identify Effective Peripheral Artery Disease Treatments in Chronic Kidney Disease1R01HL151351-01A1 | Chang, Tara I-Hsin | STANFORD UNIVERSITY, CA | First-year cost $354,432 | Study section ZHL1 |
| FY2021 | Optimizing Stroke Prophylaxis of Acute Atrial Fibrillation with an Electronic Clinical Decision Support Tool: A Stepped-Wedge Cluster Randomized Trial Design1R01HL157598-01 | Kea, Bory | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $297,000 | Study section ZHL1 |
| FY2020 | Investigating Circadian Mechanisms of Cellular Resilience: Rhythmic Condensates, Disorder, and Stress1R01HL151368-01 | Lipton, Jonathan Oren | BOSTON CHILDREN'S HOSPITAL, MA | First-year cost $424,338 | Study section ZHL1 |
| FY2020 | Prenatal pulmonary cell gene editing to cure monogenic lung diseases1R01HL151352-01 | Peranteau, William H. | CHILDREN'S HOSP OF PHILADELPHIA, PA | First-year cost $409,693 | Study section ZHL1 |
| FY2020 | Leveraging multiomics and advanced mouse models to delineate mechanisms underlying sex‐specific differences in recovery and repair after neonatal hyperoxia exposure in the developing lung1R01HL146395-01A1 | Lingappan, Krithika | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $384,700 | Study section ZHL1 |
| FY2020 | Economic modeling to understand the relationship between clinicians and outcomes of mechanically ventilated patients1R01HL146386-01A1 | Kerlin, Meeta Prasad | UNIVERSITY OF PENNSYLVANIA, PA | First-year cost $382,139 | Study section ZHL1 |
| FY2020 | SSRI Exposure and Ventricular Development from Bench to Bedside: A Prospective Study to Determine if Maternal Depression Treatment Impacts Offspring Cardiac Development1R01HL146363-01A1 | Haskell, Sarah Elizabeth | UNIVERSITY OF IOWA, IA | First-year cost $364,803 | Study section ZHL1 |
| FY2020 | Prebiotics to Optimize the Microbiota and Improve Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation1R01HL151365-01 | Sung, Anthony | DUKE UNIVERSITY, NC | First-year cost $362,250 | Study section ZHL1 |
| FY2020 | Understanding of a neurophenotype in hemophilia A1R01HL146392-01A1 | Staber, Janice Marierose | UNIVERSITY OF IOWA, IA | First-year cost $344,900 | Study section ZHL1 |
| FY2020 | Evaluating the Safety and Efficacy of Targeting the Contact Pathway to Prevent Device Associated Thrombosis.1R01HL151367-01 | Shatzel, Joseph James | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $307,013 | Study section ZHL1 |
| FY2019 | Molecular Interrogation of the Host-Pathogen Interface in Idiopathic Subglottic Stensosis1R01HL146401-01 | Gelbard, Alexander | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | First-year cost $382,500 | Study section ZHL1 |
| FY2019 | Malaria variant surface antigen expression and vulnerability to disease in Malian children with Hemoglobin C trait1R01HL146377-01 | Travassos, Mark A | UNIVERSITY OF MARYLAND BALTIMORE, MD | First-year cost $370,799 | Study section ZHL1 |
| FY2019 | The Role of RNA Modifications in Heart Failure1R01HL146381-01 | Holley, Christopher Lee | DUKE UNIVERSITY, NC | First-year cost $361,688 | Study section ZHL1 |
| FY2019 | Roadmap 2.0: A randomized controlled trial using a technology-mediated platform in family caregivers of BMT patients1R01HL146354-01 | Choi, Sung Won | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $351,000 | Study section ZHL1 |
| FY2019 | Elucidating tensin1-associated signals that promote fibronectin matrix assembly and lung fibrosis1R01HL146402-01 | Sandbo, Nathan K | UNIVERSITY OF WISCONSIN-MADISON, WI | First-year cost $344,250 | Study section ZHL1 |
| FY2019 | Emerging factors in the pathophysiology of endothelial dysfunction in HIV+ women1R01HL147660-01 | Hays, Allison G | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $283,500 | Study section ZHL1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.